HIV incidence and scale-up of prevention in western Kenya

The Lancet HIV

Volumn 5, Issue 5, 2018, Pages e204-e205

  Sewankambo, Nelson K ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; DISEASE ELIMINATION; ENDEMIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KENYA; MORTALITY; NOTE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCALE UP; VIRUS TRANSMISSION;

HIV INFECTIONS; HUMANS; INCIDENCE; KENYA;

EID: 85045058771     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(18)30042-0     Document Type: Note

References (10)

1. Borgdorf, MW, Kwaro, D, Obor, D, et al. Reduction of HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision, a population-based cohort analysis. Lancet HIV, 2018 published online April 8. http://dx.doi.org/10.1016/S2352-3018(18)30025-0.
2. Tanser, F, Barnighausen, T, Grapsa, E, Zaidi, J, Newell, ML, High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 339 (2013), 966–971.
3. Kong, X, Kigozi, G, Ssekasanvu, J, et al. Association of medical male circumcision and antiretroviral therapy scale-up with community HIV incidence in Rakai, Uganda. JAMA 316 (2016), 182–190.
4. Granich, RM, Gilks, CF, Dye, C, De Cock, KM, Williams, BG, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373 (2009), 48–57.
5. Eaton, JW, Johnson, LF, Salomon, JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med, 9, 2012, e10001245.
6. Auvert, B, Taljaard, D, Lagarde, E, Sobngwi-Tambekou, J, Sitta, R, Puren, A, Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med, 2, 2005, e298.
7. Bailey, RC, Moses, S, Parker, CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet 369 (2007), 643–656.
8. Gray, RH, Kigozi, G, Serwadda, D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet 369 (2007), 657–666.
9. Cohen, MS, Chen, YQ, McCauley, M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med 375 (2016), 830–839.
10. Grabowski, MK, Serwadda, DM, Gray, RH, et al. HIV prevention efforts and incidence of HIV in Uganda. N Engl J Med 377 (2017), 2154–2166.